RecruitingNCT03845946

CLOUD-R HAE REGISTRY

International Registry of Isolated Angioedema


Sponsor

University Hospital, Grenoble

Enrollment

1,000 participants

Start Date

Sep 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Angioedema is a disease characterized by the appearance of self-limiting edema that last 1-5 days and affect the subcutaneous tissue and/or gastrointestinal and oropharyngeal mucosa. In this last location edema can be lethal causing asphyxia, in all other cases full recovery is complete. Attacks can appear as part of the syndrome urticaria angioedema and can be of allergic origin. But there is a group of non-allergic angioedema that occur without hives and can be either hereditary or acquired. These angioedema are identified in some cases on the basis of etiology, in others are identified by the mediator and an overall classification of these forms of angioedema was published in 2014 as a result of a consent conference organized by the proponents of this registry. Being these forms of angioedema rare, there are not significative case studies inclusive of a high number of patients. This registry aims to collect in a single place a high number of subjects with recurring angioedema and without urticaria.


Eligibility

Inclusion Criteria4

  • Any patient with isolated angioedema without associated wheals.
  • Patients with hereditary angioedema with or without C1 deficiency.
  • Major patient with consent (signature)
  • Minor patient whose parents / legal guardians have given their consent (signature)

Exclusion Criteria2

  • Patient unable to give consent.
  • Wheals with angioedema

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALangioedema

electronic tracking book


Locations(1)

University Hospital Grenoble

Grenoble, Isere, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03845946


Related Trials